India's markets are faltering, with weak earnings and continued tariff threats from the US. The rupee struggles with limited foreign portfolio inflows. US President Trump's proposed tariffs on pharmaceuticals and India's purchase of Russian oil add to uncertainty. Meanwhile, global markets brace for a possible 15% pullback, with rising concerns about US economic slowdowns.